Compare, Analyse Cadila Healthcare with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs ADCOCK INGRAM (S. Africa) - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CADILA HEALTHCARE   ADCOCK INGRAM
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-20
ADCOCK INGRAM
Jun-14
CADILA HEALTHCARE/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs352378-   
Low Rs207272-   
Sales per share (Unadj.) Rs139.2112.4-  
Earnings per share (Unadj.) Rs11.8-28.3-  
Cash flow per share (Unadj.) Rs18.6-23.5-  
Dividends per share (Unadj.) Rs3.500-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs101.488.2-  
Shares outstanding (eoy) m1,023.74168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.02.9 69.4%   
Avg P/E ratio x23.7-11.5 -206.8%  
P/CF ratio (eoy) x15.0-13.9 -108.6%  
Price / Book Value ratio x2.83.7 74.8%  
Dividend payout %29.80-   
Avg Mkt Cap Rs m286,03354,871 521.3%   
No. of employees `00013.44.3 312.3%   
Total wages/salary Rs m24,1453,444 701.1%   
Avg. sales/employee Rs Th10,632.74,417.5 240.7%   
Avg. wages/employee Rs Th1,801.2802.2 224.5%   
Avg. net profit/employee Rs Th898.5-1,113.1 -80.7%   
INCOME DATA
Net Sales Rs m142,53118,964 751.6%  
Other income Rs m1,139133 857.7%   
Total revenues Rs m143,67019,097 752.3%   
Gross profit Rs m24,198-3,286 -736.3%  
Depreciation Rs m6,965818 851.0%   
Interest Rs m3,418514 665.4%   
Profit before tax Rs m14,954-4,486 -333.4%   
Minority Interest Rs m288-13 -2,303.3%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,198280 1,140.9%   
Profit after tax Rs m12,044-4,779 -252.0%  
Gross profit margin %17.0-17.3 -98.0%  
Effective tax rate %21.4-6.2 -342.2%   
Net profit margin %8.5-25.2 -33.5%  
BALANCE SHEET DATA
Current assets Rs m87,15413,890 627.5%   
Current liabilities Rs m82,6947,815 1,058.1%   
Net working cap to sales %3.132.0 9.8%  
Current ratio x1.11.8 59.3%  
Inventory Days Days71111 64.4%  
Debtors Days Days94124 75.7%  
Net fixed assets Rs m133,2368,096 1,645.6%   
Share capital Rs m1,02488 1,163.0%   
"Free" reserves Rs m102,7330-   
Net worth Rs m103,75714,885 697.1%   
Long term debt Rs m32,1465,231 614.5%   
Total assets Rs m236,86628,119 842.4%  
Interest coverage x5.4-7.7 -69.5%   
Debt to equity ratio x0.30.4 88.2%  
Sales to assets ratio x0.60.7 89.2%   
Return on assets %6.5-15.2 -43.0%  
Return on equity %11.6-32.1 -36.2%  
Return on capital %13.7-19.8 -69.3%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m38,2480-   
CASH FLOW
From Operations Rs m25,0541,619 1,547.7%  
From Investments Rs m-10,123-497 2,036.7%  
From Financial Activity Rs m-10,9424,747 -230.5%  
Net Cashflow Rs m3,9895,869 68.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.21 Rs / ZAR

Compare CADILA HEALTHCARE With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare CADILA HEALTHCARE With: DR. REDDYS LAB  PIRAMAL ENTERPRISES  GLENMARK PHARMA  ORCHID PHARMA  TORRENT PHARMA  



Today's Market

Sensex Trades Over 300 Points Higher, Dow Futures Up by 86 Points(12:30 pm)

Share markets in India are presently trading on a strong note. The BSE Sensex is trading up by 379 points, up 0.8% at 49,585 levels.

Related Views On News

AUROBINDO PHARMA at 52 Week High; BSE 500 Index Up 1.0% (Market Updates)

May 10, 2021 | Updated on May 10, 2021

AUROBINDO PHARMA share price has hit a 52-week high. It is presently trading at Rs 1,047. BSE 500 Index is up by 0.7% at 20,165. Within the BSE 500, AUROBINDO PHARMA (up 2.4%) and GMDC (up 16.0%) are among the top gainers, while top losers are CHOLAMANDALAM INVEST and COFORGE.

CADILA HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 40.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 40.6% YoY). Sales on the other hand came in at Rs 38 bn (up 4.3% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2019-20 Annual Report Analysis (Annual Result Update)

Oct 26, 2020 | Updated on Oct 26, 2020

Here's an analysis of the annual report of CADILA HEALTHCARE for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

CADILA HEALTHCARE Announces Quarterly Results (1QFY21); Net Profit Up 49.3% (Quarterly Result Update)

Aug 21, 2020 | Updated on Aug 21, 2020

For the quarter ended June 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 49.3% YoY). Sales on the other hand came in at Rs 36 bn (up 4.1% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away? (Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

FREE Event: Discover Your First Stock for a Potential Rs 7 Crore in Long-term Wealth
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

CADILA HEALTHCARE SHARE PRICE


May 10, 2021 02:23 PM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 8-QTR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

FEATURED VIDEOS

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

More Featured Videos

MARKET STATS